2025. TREATMENT OF TYPE 2 DIABETES MELLITUS WITH GLP-1 RECEPTOR AGONISTS, CHRONIC KIDNEY DISEASE AND INFLUENCE ON CARDIOVASCULAR RISK. TRAKIA JOURNAL OF SCIENCES. 23, Supplement 1 (Oct. 2025), 6. DOI:https://doi.org/10.15547/tjs.2025.s.01.004.